147 related articles for article (PubMed ID: 9126094)
1. Which patients with prostatic carcinoma require a staging bone scan?
Kemp PM; Maguire GA; Bird NJ
Br J Urol; 1997 Apr; 79(4):611-4. PubMed ID: 9126094
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
[TBL] [Abstract][Full Text] [Related]
3. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
[TBL] [Abstract][Full Text] [Related]
4. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
[TBL] [Abstract][Full Text] [Related]
5. Bone scan in initial staging of prostate cancer.
Boughattas S; Letaief B; Hassine H; Chatti K; Essabah H
Tunis Med; 2003 Jun; 81(6):400-6. PubMed ID: 14534946
[TBL] [Abstract][Full Text] [Related]
6. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
Wolff JM; Bares R; Jung PK; Buell U; Jakse G
Urol Int; 1996; 56(3):169-73. PubMed ID: 8860738
[TBL] [Abstract][Full Text] [Related]
8. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
9. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
McArthur C; McLaughlin G; Meddings RN
Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
[TBL] [Abstract][Full Text] [Related]
10. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
[TBL] [Abstract][Full Text] [Related]
11. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
12. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
Vijayakumar V; Vijayakumar S; Quadri SF; Blend MJ
Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394
[TBL] [Abstract][Full Text] [Related]
13. Using prostate-specific antigen to eliminate the staging radionuclide bone scan.
Lee CT; Oesterling JE
Urol Clin North Am; 1997 May; 24(2):389-94. PubMed ID: 9126236
[TBL] [Abstract][Full Text] [Related]
14. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
Oesterling JE; Martin SK; Bergstralh EJ; Lowe FC
JAMA; 1993 Jan; 269(1):57-60. PubMed ID: 7677962
[TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer.
Miller PD; Eardley I; Kirby RS
Br J Urol; 1992 Sep; 70(3):295-8. PubMed ID: 1384920
[TBL] [Abstract][Full Text] [Related]
16. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
[TBL] [Abstract][Full Text] [Related]
17. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
Bruwer G; Heyns CF; Allen FJ
Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
[TBL] [Abstract][Full Text] [Related]
18. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.
Lai MH; Luk WH; Chan JC
Urol Oncol; 2011; 29(3):275-9. PubMed ID: 19734069
[TBL] [Abstract][Full Text] [Related]
19. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.
O'Sullivan JM; Norman AR; Cook GJ; Fisher C; Dearnaley DP
BJU Int; 2003 Nov; 92(7):685-9. PubMed ID: 14616446
[TBL] [Abstract][Full Text] [Related]
20. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.
Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y
Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
